Conference · San Francisco, California
Oncology Clinical Trials 2013
Biotechnology · Laboratory · Medicine
Key numbers
- Editions on record
- 5first in 2012
About Strategies for Clinical Oncology Drug Development
The recent breakthroughs in understanding of the molecular biology of cancer have led to an unprecedented number of new targets in oncology drug development. Many of these are already advancing to the clinical stages, making oncology clinical trials the most prevalent across therapeutic areas. The success of an oncology trial depends on many factors, the most important being the quality of pre-clinical data that provides a testable hypothesis. Biostatistical, scientific, organizational, regulatory, ethical and economic ingredients are equally important for advancing clinical development of a drug.
Who should attend: Scientists, biostatisticians, project managers, research investigators and other specialists involved in oncology clinical trials
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 19–24 Feb 2017 | Moscone Convention Center San Francisco, California | — | — |
| 2015 | 13–15 Feb 2015 | Moscone Convention Center San Francisco, California | — | — |
| 2014 | 9–14 Feb 2014 | Moscone Convention Center San Francisco, California | — | — |
| 2013 | 13–15 Feb 2013 | Moscone Convention Center San Francisco, California | — | — |
| 2012 | 21 Feb – 23 Aug 2012 | Moscone Convention Center San Francisco, California | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.